Search - tctmd.com

Displaying 401 - 420 of 15660

Sort: Relevancy | Date

Presentation TCT 2016

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Presenter: Stephen Balter, Donald L. Miller

November 01, 2016

Presentation TCT 2016

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Presentation TCT 2016

Learning the Business of Interventional Cardiology

Presenter: Ehtisham Mahmud, Manish A. Parikh, Ethan C Korngold

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Presenter: Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Presenter: John A. Ambrose, Peter H. Stone

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Presenter: Koen Deloose, William A. Gray, Prakash Krishnan

November 01, 2016

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Presenter: Stephen Balter, Sanjog Kalra

November 01, 2016

Presentation TCT 2016

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

I Used to Be an Interventional Cardiologist: Psychological Impact

Presenter: David O. Williams, George W. Vetrovec

November 01, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Presenter: Koen Deloose, William A. Gray, Kenneth Rosenfield

November 01, 2016

Presentation TCT 2016

Percutaneous Large Bore Access: Technique and Pitfalls

Presenter: Peter A. Schneider, Zvonimir Krajcer

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Presenter: John A. Ambrose, Peter H. Stone, James E. Muller

November 01, 2016

Advertisement

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Planning and Performing TAVR in the Patient With CKD

Learning the Business of Interventional Cardiology

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Optimal Approach to Persistent Type II Endoleaks with Sac Expansion

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia?

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex

Post-TAVR Valve Thickening: Current Data and Open Questions

Hot: Is High Dose Due to Operator Preferences or Patient Characteristics?

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

I Used to Be an Interventional Cardiologist: Psychological Impact

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials II - Lutonix

Percutaneous Large Bore Access: Technique and Pitfalls

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content